Showing results (41-50 of 122) with videos related to
Sort By:
Pageof 13
Gastroenterology & Hepatology|May 17, 2016
Fertility and Contraception in Women With Inflammatory Bowel DiseaseJason Martin, Sunanda V Kane, Linda A FeaginsSouthern Medical Journal|March 24, 2006
Factitious diarrhea masquerading as refractory celiac diseaseRajesh N Keswani, Jenny Sauk, Sunanda V KaneThe American Journal of Gastroenterology|September 9, 2008
Cost-effectiveness of 5-aminosalicylic acid therapy for maintenance of remission in ulcerative colitisEugene F Yen, Sunanda V Kane, Uri LadabaumAdvances in Therapy|October 20, 2009
Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patientsSunanda V Kane, Jingdong Chao, Parvez M MulaniBMJ Open Quality|January 12, 2025
Improving 1-year liver allograft survival hazard ratiosResham Ramkissoon, Ashley Rosier, Savitha Iyengar, et al.The American Journal of Gastroenterology|May 7, 2010
Mentoring in gastroenterologyAnne C Travis, Philip O Katz, Sunanda V KaneDigestive Diseases and Sciences|September 1, 2011
Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions databaseSunanda V Kane, Michael Sumner, Dory Solomon, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 25, 2013
Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel diseaseNeena S Abraham, Peter Richardson, Diana Castillo, et al.Inflammatory Bowel Diseases|May 4, 2012
Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologicsSiddharth Singh, Neeraj Kumar, Edward V Loftus, et al.ACG Case Reports Journal|April 4, 2025
De Novo Crohn's Disease 3 Years Following Immune Checkpoint Inhibitor TherapyMatthew G Bell, Manuel Bonfim Braga Neto, Sunanda V KanePageof 13